Morepen Laboratories LimitedNSE: MOREPENLAB

Press Release Apr 29 2025

· Issued by Morepen Laboratories Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

Morepen Laboratories Limited has announced the launch of Resmetirom, a new drug for fatty liver disease, following clearance from the CDSCO for bioequivalence studies. This development positions Morepen as one of the first Indian companies to enter this therapeutic area, aiming to serve both domestic and international markets. The company emphasizes its integrated capabilities and regulatory strength as key advantages in bringing this innovation to market. The press release serves to inform stakeholders about this significant advancement in Morepen's product offerings.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Morepen Laboratories Limited on 6ix

Earlier from Morepen Laboratories

Later from Morepen Laboratories

All Morepen Laboratories news releases